Skip to main content

Artificial Intelligence powered epilepsy diagnostics

Project description

Technological advances improve classification of seizure types

The most common serious brain disorder worldwide, epilepsy affects more than 65 million people, including six million in Europe alone. Recent studies show that, if properly treated, up to 70 % of people who suffer from seizures could live productive and fulfilling lives. However, effective treatment hinges on the limitations of current diagnostic methods. Therefore, improving these methods in order to select the best treatment is key. The EU-funded EPINOSTICS project will develop new technology that can automatically detect and classify all motor seizure types and deliver important health benefits globally. The aim is to improve treatment options so that epilepsy is prevented from impairing the physical, psychological and social functioning of those affected.

Call for proposal

See other projects for this call

Funding Scheme

SME-2b - SME Instrument (grant only and blended finance)


Biokatu 10
33520 Tampere
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 1 881 250